Symbols / RXDX
RXDX Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck - Yahoo Finance Mon, 17 Apr 2023 07
- Why Is Prometheus Biosciences (RXDX) Stock Up 175% Today? - InvestorPlace Wed, 07 Dec 2022 08
- Why This Small Biotech Stock Just Rocketed 176% - Investor's Business Daily hu, 08 Dec 2022 08
- Merck’s Deal for Prometheus Expected to Generate Billions in Additional Sales - Barron's Mon, 17 Apr 2023 07
- Prometheus Biosciences: Profit Taking Lurking Ahead (NASDAQ:RXDX) - Seeking Alpha ue, 28 Feb 2023 08
- Prometheus Biosciences Announces Upsized Pricing of Initial Public Offering - PR Newswire hu, 11 Mar 2021 08
- RXDX Stock Alert: The $10.8 Billion Reason Prometheus Biosciences Is Surging Today - InvestorPlace Mon, 17 Apr 2023 07
- Prometheus Biosciences, Inc. Announces Pricing of Public Upsized $500 Million Offering of Common Stock - GlobeNewswire hu, 08 Dec 2022 08
- Merck Snags $10.8 Billion Buyout As Keytruda Declines Loom - Investor's Business Daily Mon, 17 Apr 2023 07
- Why Shares of Prometheus Biosciences Slumped This Week - The Motley Fool Fri, 02 Dec 2022 08
- Merck Acquires Prometheus Biosciences for $10.8 Billion - Investopedia Mon, 17 Apr 2023 07
- Prometheus Biosciences, Inc. Announces Cessation of Keith W. Marshall as CFO - marketscreener.com Fri, 16 Jun 2023 07
- Prometheus Biosciences (RXDX) Stock Price, News & Analysis - MarketBeat hu, 09 Jul 2015 21
- Prometheus Bio’s IPO raises $190M for inflammatory bowel disease R&D - MedCity News Fri, 12 Mar 2021 08
- The Truth About Prometheus Biosciences (RXDX): Tiny Ticker, Huge Exit – But Is It Still Worth the Hype? - AD HOC NEWS Sat, 03 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for RXDX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|